Infection with MERS-CoV causes lethal pneumonia in the common marmoset

Darryl Falzarano1, Emmie de Wit1, Friederike Feldmann2

  • 1Disease Modeling and Transmission, Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, Montana, United States of America.

Plos Pathogens
|August 22, 2014
PubMed

Insights

A new common marmoset model for Middle East respiratory syndrome coronavirus (MERS-CoV) infection causes severe pneumonia. This severe MERS-CoV disease model is crucial for developing effective vaccines and treatments.

Area of Science:

  • Virology
  • Infectious Diseases
  • Animal Models

Background:

  • A robust disease model is critical for developing Middle East respiratory syndrome coronavirus (MERS-CoV) countermeasures.
  • Existing rhesus macaque models exhibit variable disease severity, hindering countermeasure analysis.

Purpose of the Study:

  • To evaluate the common marmoset as a susceptible and responsive model for MERS-CoV infection.
  • To establish a severe, partially lethal MERS-CoV disease model for pathogenesis and therapeutic studies.

Main Methods:

  • Computational modeling predicted MERS-CoV spike glycoprotein and human dipeptidyl peptidase 4 receptor interactions.
  • Common marmosets were inoculated via combined intratracheal, intranasal, oral, and ocular routes.
  • Disease progression, viral loads, lung pathology, and host immune responses were assessed.

Main Results:

  • Most marmosets developed progressive, severe pneumonia, with some requiring euthanasia.
  • Extensive lung lesions and high viral loads were observed in all necropsied animals.
  • Viremia and induction of immune and inflammatory pathways were detected via RNAseq.

Conclusions:

  • The common marmoset provides a valuable, severe, and partially lethal disease model for MERS-CoV.
  • This model will significantly advance the assessment of MERS-CoV vaccines and therapeutics.
  • It facilitates detailed studies into MERS-CoV pathogenesis.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.5K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
78
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
20
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
189
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.3K